HLS Therapeutics Inc. (HLS.TO)
CAD 4.4
(0.92%)
CAD 4.4
(0.92%)
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2023 | 82.46 Million USD | -1.55% |
| 2022 | 83.76 Million USD | -1.41% |
| 2021 | 84.96 Million USD | -12.4% |
| 2020 | 96.98 Million USD | 11.39% |
| 2019 | 87.06 Million USD | -5.06% |
| 2018 | 91.7 Million USD | -32.92% |
| 2017 | 136.7 Million USD | -6.39% |
| 2016 | 146.04 Million USD | -10.36% |
| 2015 | 162.93 Million USD | 0.0% |
| 2014 | - USD | 0.0% |
| 2013 | - USD | 0.0% |
| 2012 | - USD | 0.0% |
| 2011 | - USD | -100.0% |
| 2010 | 307.95 Thousand USD | -86.35% |
| 2009 | 2.25 Million USD | -70.05% |
| 2008 | 7.53 Million USD | -35.72% |
| 2007 | 11.72 Million USD | 183.98% |
| 2006 | 4.12 Million USD | 91.63% |
| 2005 | 2.15 Million USD | 0.0% |
| 2004 | - USD | 0.0% |
| 2003 | - USD | 0.0% |
| 2002 | - USD | 0.0% |
| 2001 | - USD | -100.0% |
| 2000 | 3.25 Million USD | 34.5% |
| 1999 | 2.41 Million USD | -63.18% |
| 1998 | 6.56 Million USD | -19.03% |
| 1997 | 8.1 Million USD | 10825.71% |
| 1996 | 74.19 Thousand USD | 0.0% |
| Year | Long Term Debt | Long Term Debt Growth |
|---|---|---|
| 2024 Q2 | 77.96 Million USD | -2.41% |
| 2024 Q1 | 79.97 Million USD | -2.9% |
| 2023 FY | 82.46 Million USD | -1.55% |
| 2023 Q1 | 82.39 Million USD | -1.63% |
| 2023 Q2 | 81.55 Million USD | -1.02% |
| 2023 Q3 | 85.46 Million USD | 4.8% |
| 2023 Q4 | 82.46 Million USD | -3.51% |
| 2022 FY | 83.76 Million USD | -1.41% |
| 2022 Q2 | 79.07 Million USD | -3.61% |
| 2022 Q1 | 82.03 Million USD | -3.44% |
| 2022 Q3 | 84.81 Million USD | 7.27% |
| 2022 Q4 | 83.76 Million USD | -1.25% |
| 2021 Q1 | 93.96 Million USD | -3.12% |
| 2021 FY | 84.96 Million USD | -12.4% |
| 2021 Q3 | 87.45 Million USD | -4.01% |
| 2021 Q4 | 84.96 Million USD | -2.85% |
| 2021 Q2 | 91.1 Million USD | -3.04% |
| 2020 Q1 | 85.08 Million USD | -2.27% |
| 2020 Q4 | 96.98 Million USD | -2.76% |
| 2020 FY | 96.98 Million USD | 11.39% |
| 2020 Q3 | 99.73 Million USD | 19.7% |
| 2020 Q2 | 83.32 Million USD | -2.08% |
| 2019 Q1 | 91.11 Million USD | -0.64% |
| 2019 Q4 | 87.06 Million USD | -1.98% |
| 2019 FY | 87.06 Million USD | -5.06% |
| 2019 Q2 | 89.91 Million USD | -1.32% |
| 2019 Q3 | 88.82 Million USD | -1.21% |
| 2018 FY | 91.7 Million USD | -32.92% |
| 2018 Q1 | 130.56 Million USD | -4.49% |
| 2018 Q2 | 125.25 Million USD | -4.07% |
| 2018 Q3 | 97.81 Million USD | -21.9% |
| 2018 Q4 | 91.7 Million USD | -6.25% |
| 2017 FY | 136.7 Million USD | -6.39% |
| 2017 Q4 | 136.7 Million USD | -2.56% |
| 2017 Q3 | 140.29 Million USD | 0.0% |
| 2017 Q2 | - USD | 0.0% |
| 2017 Q1 | - USD | -100.0% |
| 2016 Q2 | - USD | 0.0% |
| 2016 Q3 | - USD | 0.0% |
| 2016 Q4 | 146.04 Million USD | 0.0% |
| 2016 FY | 146.04 Million USD | -10.36% |
| 2016 Q1 | - USD | 0.0% |
| 2015 Q4 | - USD | 0.0% |
| 2015 Q2 | - USD | 0.0% |
| 2015 FY | 162.93 Million USD | 0.0% |
| 2015 Q3 | - USD | 0.0% |
| 2015 Q1 | - USD | 0.0% |
| 2014 FY | - USD | 0.0% |
| 2014 Q1 | - USD | 0.0% |
| 2014 Q3 | - USD | 0.0% |
| 2014 Q4 | - USD | 0.0% |
| 2014 Q2 | - USD | 0.0% |
| 2013 Q3 | - USD | 0.0% |
| 2013 FY | - USD | 0.0% |
| 2013 Q4 | - USD | 0.0% |
| 2013 Q2 | - USD | 0.0% |
| 2013 Q1 | - USD | 0.0% |
| 2012 Q4 | - USD | 0.0% |
| 2012 Q3 | - USD | 0.0% |
| 2012 FY | - USD | 0.0% |
| 2012 Q2 | - USD | 0.0% |
| 2012 Q1 | - USD | 0.0% |
| 2011 Q3 | - USD | 0.0% |
| 2011 Q2 | - USD | 0.0% |
| 2011 Q1 | - USD | -100.0% |
| 2011 FY | - USD | -100.0% |
| 2011 Q4 | - USD | 0.0% |
| 2010 Q2 | - USD | -100.0% |
| 2010 Q3 | - USD | 0.0% |
| 2010 Q4 | 307.95 Thousand USD | 0.0% |
| 2010 Q1 | 605.25 Thousand USD | -73.18% |
| 2010 FY | 307.95 Thousand USD | -86.35% |
| 2009 Q4 | 2.25 Million USD | 0.0% |
| 2009 FY | 2.25 Million USD | -70.05% |
| 2009 Q1 | 6.68 Million USD | -11.32% |
| 2009 Q2 | 6.6 Million USD | -1.12% |
| 2009 Q3 | - USD | -100.0% |
| 2008 FY | 7.53 Million USD | -35.72% |
| 2008 Q4 | 7.53 Million USD | -19.95% |
| 2008 Q1 | 10.77 Million USD | -8.11% |
| 2008 Q2 | - USD | -100.0% |
| 2008 Q3 | 9.41 Million USD | 0.0% |
| 2007 Q4 | 11.72 Million USD | 113.64% |
| 2007 Q2 | 4.02 Million USD | 0.0% |
| 2007 Q1 | - USD | -100.0% |
| 2007 FY | 11.72 Million USD | 183.98% |
| 2007 Q3 | 5.48 Million USD | 36.39% |
| 2006 FY | 4.12 Million USD | 91.63% |
| 2006 Q4 | 4.12 Million USD | -24.84% |
| 2006 Q3 | 5.49 Million USD | 295.34% |
| 2006 Q2 | 1.38 Million USD | -13.43% |
| 2006 Q1 | 1.6 Million USD | -25.5% |
| 2005 Q4 | 2.15 Million USD | 0.0% |
| 2005 Q3 | - USD | 0.0% |
| 2005 Q2 | - USD | 0.0% |
| 2005 Q1 | - USD | 0.0% |
| 2005 FY | 2.15 Million USD | 0.0% |
| 2004 Q1 | - USD | 0.0% |
| 2004 FY | - USD | 0.0% |
| 2004 Q3 | - USD | 0.0% |
| 2004 Q2 | - USD | 0.0% |
| 2004 Q4 | - USD | 0.0% |
| 2003 Q4 | - USD | 0.0% |
| 2003 FY | - USD | 0.0% |
| 2003 Q1 | - USD | 0.0% |
| 2003 Q2 | - USD | 0.0% |
| 2003 Q3 | - USD | 0.0% |
| 2002 Q4 | - USD | 0.0% |
| 2002 Q1 | - USD | 0.0% |
| 2002 Q2 | - USD | 0.0% |
| 2002 Q3 | - USD | 0.0% |
| 2002 FY | - USD | 0.0% |
| 2001 FY | - USD | -100.0% |
| 2001 Q1 | 2.21 Million USD | -31.92% |
| 2001 Q2 | 1.75 Million USD | -20.87% |
| 2001 Q3 | - USD | -100.0% |
| 2001 Q4 | - USD | 0.0% |
| 2000 Q3 | - USD | 0.0% |
| 2000 FY | 3.25 Million USD | 34.5% |
| 2000 Q1 | - USD | -100.0% |
| 2000 Q4 | 3.25 Million USD | 0.0% |
| 1999 Q3 | - USD | 0.0% |
| 1999 FY | 2.41 Million USD | -63.18% |
| 1999 Q1 | - USD | -100.0% |
| 1999 Q4 | 2.41 Million USD | 0.0% |
| 1998 FY | 6.56 Million USD | -19.03% |
| 1998 Q4 | 6.56 Million USD | 0.0% |
| 1998 Q3 | - USD | 0.0% |
| 1997 Q3 | - USD | 0.0% |
| 1997 Q2 | - USD | 0.0% |
| 1997 FY | 8.1 Million USD | 10825.71% |
| 1997 Q1 | - USD | 0.0% |
| 1996 FY | 74.19 Thousand USD | 0.0% |
| Name | Long Term Debt | Long Term Debt Difference |
|---|---|---|
| Aurora Cannabis Inc. | 47.57 Million CAD | -73.34% |
| Avicanna Inc. | 95.36 Thousand CAD | -86375.745% |
| Avant Brands Inc. | 1.74 Million CAD | -4636.646% |
| Cardiol Therapeutics Inc. | 158.53 Thousand CAD | -51917.889% |
| Crescita Therapeutics Inc. | 815 Thousand CAD | -10018.405% |
| Knight Therapeutics Inc. | 44.01 Million CAD | -87.352% |
| MediPharm Labs Corp. | 69 Thousand CAD | -119414.493% |
| OrganiGram Holdings Inc. | 79 Thousand CAD | -104286.076% |
| Canopy Growth Corporation | 493.29 Million CAD | 83.283% |
| Willow Biosciences Inc. | 594 Thousand CAD | -13782.997% |
| Auxly Cannabis Group Inc. | 81.38 Million CAD | -1.33% |